Trastuzumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Trastuzumab and local guidelines before prescribing.

HER2 monoclonal antibody

Mechanism

HER2 monoclonal antibody.

Uses

HER2-positive breast and gastric cancer.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Cardiomyopathy and heart failure, infusion reactions, diarrhoea, neutropenia.

Interactions

Anthracyclines increase cardiotoxicity.

Contraindications and cautions

Severe dyspnoea at rest, heart failure

Monitoring

LVEF, FBC

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Baseline and 3-monthly echocardiogram; stop if LVEF falls.

More from the textbook: uses, cautions and other points
Where it is discussed in the book